Status:
UNKNOWN
Pain Treatment in a Breast Cancer Population. PaiNEd Study.
Lead Sponsor:
Universidad de Granada
Conditions:
Breast Cancer
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
The objectives of this study are: 1) To design and implement the PaiNEd system for the evaluation and treatment based on Pain Neuroscience Education (PNE) in cancer survivors with sequelae derived fro...
Detailed Description
People who have suffered cancer often do not find an adequate therapeutic response for the sequelae derived from its treatments. The objectives of this study are: 1) To design and implement the PaiNEd...
Eligibility Criteria
Inclusion
- Subjects over 18 years of age.
- Having undergone surgery and finished adjuvant treatment (radiotherapy and / or chemotherapy) six months or two years ago.
- Not having active cancer.
- Having pain in the regions related to the tumor area (cervical and / or brachial and / or shoulder), pain ≥ 4 (VAS 0 to 10) for\> 4 weeks
- Present musculoskeletal or functional alterations in the previous regions.
Exclusion
- Identification by the research team of physical or mental impossibility to carry out the tests of the study.
- Suffering from chronic pain or having suffered a previous trauma to the spine, head, temporomandibular joint or upper extremities.
Key Trial Info
Start Date :
April 4 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 1 2024
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT04877860
Start Date
April 4 2022
End Date
April 1 2024
Last Update
May 9 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences Faculty, University of Granada
Granada, Spain, 18071